NCT06764433

Brief Summary

The effect of GON PRF treatment applied with USG-guided proximal technique in patients who do not respond to conservative treatments for cervicogenic headache

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2023

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2024

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2024

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

January 2, 2025

Completed
6 days until next milestone

First Posted

Study publicly available on registry

January 8, 2025

Completed
Last Updated

March 2, 2026

Status Verified

February 1, 2026

Enrollment Period

10 months

First QC Date

January 2, 2025

Last Update Submit

February 26, 2026

Conditions

Keywords

Cervical painVisual Analog Scaleheadacheinterventionalpulsed radiofrequency treatmentsecondary headache disordersspinal nerves

Outcome Measures

Primary Outcomes (1)

  • Visual Analog Scale

    Average headache severity, maximum headache severity, number of headache days (monthly) measured with a visual analog scale (VAS; 10-point VAS scoring, 0 being no pain and 10 being the highest pain intensity that can be tolerated)

    3 months

Study Arms (1)

Clinical data of the patients before and after treatment will be compared

OTHER

According to the International Classification of Headache Disorders (ICHD)-III diagnostic criteria, patients diagnosed with cervicogenic headache will undergo a proximal technique C2 level greater occipital nerve (GON) diagnostic block under ultrasound (USG) guidance, and patients with a positive response (≥50% reduction in pain or positive effect) will receive GON-PRF treatment with the same technique. This study mainly aims to evaluate the clinical efficacy and safety of GON PRF treatment applied at the C2 level under USG guidance in cervicogenic headache during the follow-up period. Our secondary aim is to determine the effects of the GON PRF treatment we applied on the analgesic drug consumption, daily life activities and sleep of the volunteers, how they generally perceive this treatment and whether there is a need for any additional treatment.

Procedure: GONPRFProcedure: Proximal GONPRF

Interventions

GONPRFPROCEDURE

GON PRF treatment, which we apply by imaging the target nerve and surrounding structures with the proximal technique (at C2 level) under USG guidance in patients who do not respond to conservative treatments for cervicogenic headache.

Clinical data of the patients before and after treatment will be compared

Ultrasound-guided pulsed radiofrequency treatment of the greater occipital nerve at the C2 level

Clinical data of the patients before and after treatment will be compared

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosed with cervicogenic headache according to ICHD-3 criteria
  • Cranial and cervical spine imaging is available
  • Number of headache days per month 5 and/or more
  • Inadequate benefit from pharmacological treatments or physical therapy methods used
  • Volunteer patients who can understand and approve the treatment and the informed consent form and who can comply with the treatment

You may not qualify if:

  • History of secondary headache other than cervicogenic headache according to ICHD-3 criteria
  • Cervical nerve root irritation and/or spinal stenosis symptoms and signs
  • Sensory deficit findings in the greater occipital nerve dermatome
  • Craniocervical defect or other anatomical abnormality in the target area or nearby the procedure
  • Local or systemic infection
  • Received nonpharmacological treatment within the last 3 months (physical therapy, botulinum toxin A, acupuncture, ozone, cognitive behavioral therapy, etc.)
  • Pregnancy or suspected pregnancy
  • Known allergy to local anesthetic drugs
  • History of malignancy
  • Known organic disease of the brain and spinal cord
  • History of cranial/cervical surgery within the last 1 year
  • Bleeding-clotting disorder or oral anticoagulant use
  • Comorbid disease that may cause headache (uncontrolled hypertension, intracranial lesion, etc.)
  • Compliance with treatment and treatment results diseases that may affect the evaluation (psychiatric disorder, dementia, etc.)
  • Those who request re-treatment due to the emergence of contralateral pain or other types of pain during the follow-up period after treatment
  • +1 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Health Sciences University, Ankara Bilkent City Hospital

Ankara, Cankaya, 06800, Turkey (Türkiye)

Location

Related Publications (1)

  • Gabrhelik T, Michalek P, Adamus M. Pulsed radiofrequency therapy versus greater occipital nerve block in the management of refractory cervicogenic headache - a pilot study. Prague Med Rep. 2011;112(4):279-87.

Related Links

MeSH Terms

Conditions

HeadachePost-Traumatic HeadacheNeck PainHeadache Disorders, Secondary

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsHeadache DisordersBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Single-center, prospective, comparative, observational study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
assoc prof dr

Study Record Dates

First Submitted

January 2, 2025

First Posted

January 8, 2025

Study Start

March 1, 2023

Primary Completion

January 1, 2024

Study Completion

December 1, 2024

Last Updated

March 2, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

I dont want to.

Locations